G

GlycoMimetics
D

GLYC

0.31510
USD
-0.01
(-2.93%)
Market Closed
Volume
31,915
EPS
-1
Div Yield
-
P/E
-1
Market Cap
20,318,895
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    F
    FIXX
    0
    (0%)
    0.000000 USD
    G
    GLMD
    -0.16000
    (-5.18%)
    2.93000 USD
    G
    GLYC
    0.02000
    (4.95%)
    0.42420 USD
    P
    PRQR
    -0.13000
    (-3.28%)
    3.83000 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    More
News

Title: GlycoMimetics

Sector: Healthcare
Industry: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.